Individual estimates of age at detectable amyloid onset for risk factor assessment

详细信息    查看全文

• 作者：Murat Bilgel^a ; ^b ; ^{murat.bilgel@nih.gov" class="auth_mail" title="E-mail the corresponding author} ; Yang An^a ; Yun Zhou^c ; Dean F. Wong^c ; Jerry L. Prince^b ; ^c ; ^d ; Luigi Ferrucci^e ; Susan M. Resnick^a
• 关键词：APOE ; Pittsburgh compound B ; PET ; Amyloid imaging ; Age at onset
• 刊名：Alzheimer's & Dementia
• 出版年：2016
• 出版时间：April 2016
• 年：2016
• 卷：12
• 期：4
• 页码：373-379
• 全文大小：655 K

文摘

Individualized estimates of age at detectable amyloid-beta (Aβ) accumulation, distinct from amyloid positivity, allow for analysis of onset age of Aβ accumulation as an outcome measure to understand risk factors.

Methods

Using longitudinal Pittsburgh compound B (PiB) positron emission tomography data from Baltimore Longitudinal Study of Aging, we estimated the age at which each PiB+ individual began accumulating Aβ. We used survival analysis methods to quantify risk of accumulating Aβ and differences in onset age of Aβ accumulation in relation to APOE ε4 status and sex among 36 APOE ε4 carriers and 83 noncarriers.

Results

Age at onset of Aβ accumulation for the APOE ε4− and ε4+ groups was 73.1 and 60.7, respectively. APOE ε4 positivity conferred a threefold risk of accumulating Aβ after adjusting for sex and education.

Discussion

Estimation of onset age of amyloid accumulation may help gauge treatment efficacy in interventions to delay symptom onset in Alzheimer's disease.